Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Merck & Co., Inc. MRK

Healthcare  —  Drug Manufacturers General
148.78 0.80 0.54% as of 25 Sep
Market cap
$365.4B
P/E
119×
S&P 500 Member Dividend Aristocrat Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Merck & Co., Inc. (MRK) P/E ratio

As of 25 September 2026, Merck & Co., Inc. (MRK) trades at a P/E ratio of 119×. Over the past ten years it has ranged from 10.7× (May 2025) to 943× (March 2024); the current reading is higher than 95% of that period. That is above the Drug Manufacturers General industry median of 24.7× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 14.5× (2.18%)
FY2024 14.8× (98.17%)
FY2023 809× 4,070.18%
FY2022 19.4× 30.59%
FY2021 14.9× (47.29%)
FY2020 28.2× 23.71%
FY2019 22.8× (27.52%)
FY2018 31.4× (45.52%)
FY2017 57.7× 40.63%
FY2016 41.0× 26.97%

Quarterly

Period P/E ratio Change
Jun 2026 103× 203.38%
Mar 2026 33.9× 134.35%
Dec 2025 14.5× 30.41%
Sep 2025 11.1× (9.10%)
42 more quarters

Against its own ten years

Low 10.7× High 943×
Ten-year median 24.4×
Current reading's percentile 95

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.5×
NVS Novartis AG compare 21.8×
AZN AstraZeneca PLC compare 24.7×
AMGN Amgen Inc. compare 25.6×
JNJ Johnson & Johnson compare 31.4×
PFE Pfizer Inc. compare 37.7×
ABBV AbbVie Inc. compare 74.7×
MRK Merck & Co., Inc. 119×
Drug Manufacturers General industry median 24.7×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on MRK